These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26552746)

  • 21. Antitumor effect of nuclear factor-κB decoy transfer by mannose-modified bubble lipoplex into macrophages in mouse malignant ascites.
    Kono Y; Kawakami S; Higuchi Y; Maruyama K; Yamashita F; Hashida M
    Cancer Sci; 2014 Aug; 105(8):1049-55. PubMed ID: 24850474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer.
    Reusser NM; Dalton HJ; Pradeep S; Gonzalez-Villasana V; Jennings NB; Vasquez HG; Wen Y; Rupaimoole R; Nagaraja AS; Gharpure K; Miyake T; Huang J; Hu W; Lopez-Berestein G; Sood AK
    Cancer Biol Ther; 2014 Aug; 15(8):1061-7. PubMed ID: 24841852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling.
    Thummuri D; Jeengar MK; Shrivastava S; Nemani H; Ramavat RN; Chaudhari P; Naidu VG
    Pharmacol Res; 2015 Sep; 99():63-73. PubMed ID: 26022736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin-treated cancer cells modulate macrophage polarization through AMPK-NF-κB signaling.
    Chiang CF; Chao TT; Su YF; Hsu CC; Chien CY; Chiu KC; Shiah SG; Lee CH; Liu SY; Shieh YS
    Oncotarget; 2017 Mar; 8(13):20706-20718. PubMed ID: 28157701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo.
    Attoub S; Sperandio O; Raza H; Arafat K; Al-Salam S; Al Sultan MA; Al Safi M; Takahashi T; Adem A
    Fundam Clin Pharmacol; 2013 Oct; 27(5):557-69. PubMed ID: 22788741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophage Blockade Using CSF1R Inhibitors Reverses the Vascular Leakage Underlying Malignant Ascites in Late-Stage Epithelial Ovarian Cancer.
    Moughon DL; He H; Schokrpur S; Jiang ZK; Yaqoob M; David J; Lin C; Iruela-Arispe ML; Dorigo O; Wu L
    Cancer Res; 2015 Nov; 75(22):4742-52. PubMed ID: 26471360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective Effects of Thymoquinone Against Convulsant Activity Induced by Lithium-Pilocarpine in a model of Status Epilepticus.
    Shao Y; Feng Y; Xie Y; Luo Q; Chen L; Li B; Chen Y
    Neurochem Res; 2016 Dec; 41(12):3399-3406. PubMed ID: 27752802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pathogenetic role for M1 macrophages in peritoneal dialysis-associated fibrosis.
    Li Q; Zheng M; Liu Y; Sun W; Shi J; Ni J; Wang Q
    Mol Immunol; 2018 Feb; 94():131-139. PubMed ID: 29306153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats.
    Zhu N; Zhao X; Xiang Y; Ye S; Huang J; Hu W; Lv L; Zeng C
    Int J Cardiol; 2016 Oct; 221():587-96. PubMed ID: 27420584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian cancer stem cells induce the M2 polarization of macrophages through the PPARγ and NF-κB pathways.
    Deng X; Zhang P; Liang T; Deng S; Chen X; Zhu L
    Int J Mol Med; 2015 Aug; 36(2):449-54. PubMed ID: 26035689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation.
    Tang X; Wang X; Zhao YY; Curtis JM; Brindley DN
    Mol Cancer; 2017 Feb; 16(1):36. PubMed ID: 28178994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer models.
    Gali-Muhtasib H; Ocker M; Kuester D; Krueger S; El-Hajj Z; Diestel A; Evert M; El-Najjar N; Peters B; Jurjus A; Roessner A; Schneider-Stock R
    J Cell Mol Med; 2008; 12(1):330-42. PubMed ID: 18366456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-fibrotic effect of thymoquinone on hepatic stellate cells.
    Ghazwani M; Zhang Y; Gao X; Fan J; Li J; Li S
    Phytomedicine; 2014 Feb; 21(3):254-60. PubMed ID: 24182989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paris saponin II inhibits human ovarian cancer cell-induced angiogenesis by modulating NF-κB signaling.
    Yang M; Zou J; Zhu H; Liu S; Wang H; Bai P; Xiao X
    Oncol Rep; 2015 May; 33(5):2190-8. PubMed ID: 25760800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Syngeneic Murine Ovarian Cancer Model Reveals That Ascites Enriches for Ovarian Cancer Stem-Like Cells Expressing Membrane GRP78.
    Mo L; Bachelder RE; Kennedy M; Chen PH; Chi JT; Berchuck A; Cianciolo G; Pizzo SV
    Mol Cancer Ther; 2015 Mar; 14(3):747-56. PubMed ID: 25589495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of M2-macrophages by tumour cells and tumour growth promotion by M2-macrophages: a quid pro quo in pancreatic cancer.
    Partecke LI; Günther C; Hagemann S; Jacobi C; Merkel M; Sendler M; van Rooijen N; Käding A; Nguyen Trung D; Lorenz E; Diedrich S; Weiss FU; Heidecke CD; von Bernstorff W
    Pancreatology; 2013; 13(5):508-16. PubMed ID: 24075516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Normalization of the ovarian cancer microenvironment by SPARC.
    Said N; Socha MJ; Olearczyk JJ; Elmarakby AA; Imig JD; Motamed K
    Mol Cancer Res; 2007 Oct; 5(10):1015-30. PubMed ID: 17951402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anti-metastasis effect of thymoquinone on human pancreatic cancer].
    Wu ZH; Chen Z; Shen Y; Huang LL; Jiang P
    Yao Xue Xue Bao; 2011 Aug; 46(8):910-4. PubMed ID: 22007514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CXCL10 alters the tumour immune microenvironment and disease progression in a syngeneic murine model of high-grade serous ovarian cancer.
    K Au K; Peterson N; Truesdell P; Reid-Schachter G; Khalaj K; Ren R; Francis JA; Graham CH; Craig AW; Koti M
    Gynecol Oncol; 2017 Jun; 145(3):436-445. PubMed ID: 28318643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elucidation of molecular mechanisms underlying the protective effects of thymoquinone against rheumatoid arthritis.
    Vaillancourt F; Silva P; Shi Q; Fahmi H; Fernandes JC; Benderdour M
    J Cell Biochem; 2011 Jan; 112(1):107-17. PubMed ID: 20872780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.